IMVT icon

Immunovant

186 hedge funds and large institutions have $2.04B invested in Immunovant in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 29 closing their positions.

Holders
186
Holders Change
+6
Holders Change %
+3.33%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
39
Increased
67
Reduced
61
Closed
29
Calls
$73.9M
Puts
$18.2M
Net Calls
+$55.6M
Net Calls Change
+$6.23M
Name Market Value Shares Shares
Change
Shares
Change %
NIP
201
Nicholas Investment Partners
California
-33,103 Closed
BAMCO Inc
202
BAMCO Inc
New York
-30,000 Closed
ETC
203
Exchange Traded Concepts
Oklahoma
-27,122 Closed
AIC
204
AWM Investment Company
New York
-25,000 Closed
GCP
205
GSA Capital Partners
United Kingdom
-24,634 Closed
SRL
206
Scientech Research LLC
New Jersey
-20,691 Closed
Allianz Asset Management
207
Allianz Asset Management
Germany
-18,837 Closed
SG Americas Securities
208
SG Americas Securities
New York
-15,944 Closed
AACP
209
Advantage Alpha Capital Partners
California
-14,975 Closed
SCM
210
Superstring Capital Management
New York
-12,447 Closed
AQR Capital Management
211
AQR Capital Management
Connecticut
-10,082 Closed
SCM
212
Soleus Capital Management
Connecticut
-9,678 Closed
EC
213
EntryPoint Capital
New York
-8,738 Closed
Acadian Asset Management
214
Acadian Asset Management
Massachusetts
-3,397 Closed
CPA
215
Capital Performance Advisors
California
-3 Closed
FCM
216
Fourpath Capital Management
Oklahoma
-1 Closed
BFM
217
Boothbay Fund Management
New York
CFGS
218
Concourse Financial Group Securities
Alabama
Nomura Asset Management
219
Nomura Asset Management
Japan
CSS
220
Cubist Systematic Strategies
Connecticut
TCA
221
Troluce Capital Advisors
Puerto Rico
KAM
222
Kazazian Asset Management
Florida
JFG
223
Jefferies Financial Group
New York